SEC Form 5 · accession 0001185185-18-000840
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ram Mukunda
Officer — Executive Chairman and CEO · Director · 10% Owner
Period of report
Mar 31, 2018
Accepted (ET)
May 10, 2018 · 6:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Sep 7, 2017 | G | 90,000 | $0.00 | D | 2,265,994 | D | |
| Common stock | Sep 7, 2017 | G | 90,000 | $0.00 | D | 2,175,994 | D |
Table II — derivative securities
No Table II lines on this filing.